EGFR and neoplasm: Subsequently, in order to exclude the effect of tumor interstitial, we used multiplex immunohistochemistry to examine immune cell infiltration in the tumor parenchyma of EGFR-mutant LUAD, removing the influence of the tumor mesenchyme on the process.